相关实验视频

Updated: May 10, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

利用树突细胞开发肺癌癌症疫苗的进展 (综述)

Hui Hu¹, Wen-Jun Chen², Chuang Sun³

¹Department of Respiratory and Critical Care, The Second Affiliated Hospital of Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China.

Oncology letters

|April 25, 2025

概括

树突细胞 (DC) 疫苗在肺癌免疫疗法方面表现有前途. 本综述审查了DC疫苗机制,临床数据和提高其在治疗肺癌患者中的有效性策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗学疫苗学疫苗学

背景情况:

肺癌仍然是全球死亡的主要原因之一.
目前的治疗方法,如向疗法和免疫检查点抑制剂都有局限性.
树突细胞 (DCs) 是抗原呈现和启动免疫反应的关键免疫细胞.

研究的目的:

审查DC疫苗在肺癌中的免疫调节机制.
分析关于DC疫苗对肺癌的安全性,可行性和疗效的临床试验数据.
确定改善DC疫苗开发和临床结果的策略.

主要方法:

对肺癌中DC疫苗的综合文献综述.
对专注于DC疫苗免疫调节的临床前和临床研究的分析.
检查临床试验数据的安全性,可行性和有效性.

主要成果:

DC疫苗显示出作为肺癌个性化免疫疗法的潜力.
临床试验表明不同程度的安全性,可行性和有效性.
了解DC疫苗机制对于优化治疗至关重要.

结论:

DC疫苗代表了肺癌治疗的有希望的途径.
需要进一步的研究和战略开发,以最大限度地提高其临床疗效.
在DC疫苗设计中的个性化方法可能会提高患者的治疗结果.

关键词:

树突细胞疫苗树突细胞疫苗树突细胞是一种树突细胞.肺癌是一种肺癌.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...